About Drug Eluting Balloons
A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).
Technavio’s analysts forecast the global drug eluting balloons market to grow at a CAGR of 27.14% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global drug eluting balloons market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of DEBs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Drug Eluting Balloons Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• B. Braun Melsungen
• Cook Medical
• C.R. Bard
• Eurocor
• Medtronic
Other prominent vendors
• Aachen Resonance
• Acrostak
• Cardionovum
• Spectranetics
Market driver
• Growing demand for cath labs
• For a full, detailed list, view our report
Market challenge
• Stringent regulatory process
• For a full, detailed list, view our report
Market trend
• Favorable reimbursement policies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• PADs
• CADs
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by product
• Peripheral DEBs
• Coronary DEBs
PART 07: Market segmentation by end-user
• Cath labs
• Hospitals
• Ambulatory surgery centers (ASCs)
PART 08: Geographical segmentation
• Drug eluting balloons market in EMEA
• DEBs market in Americas
• DEBs market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
• B. Braun Melsungen
• Cook Medical
• C.R. Bard
• Eurocor
• Medtronic
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Benefits of DEBs
Exhibit 02: Major approvals/launch of drug eluting balloons
Exhibit 03: Snapshot: Global DEBs market
Exhibit 04: Global DEBs market analysis: Developed and emerging countries
Exhibit 05: Global DEBs market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global DEBs market by product
Exhibit 08: Global drug eluting balloons by product analysis 2016
Exhibit 09: Global peripheral DEBs market 2016-2021 ($ millions)
Exhibit 10: Global coronary DEBs market 2016-2021 ($ millions)
Exhibit 11: Global DEBs market by end-users 2016
Exhibit 12: Global DEBs market by geography 2016 and 2021
Exhibit 13: Global DEBs market analysis by geography 2016
Exhibit 14: Global DEBs market by geography 2016-2021
Exhibit 15: Global DEBs market by geography 2016-2021 ($ millions)
Exhibit 16: Global DEBs market by geography: An overview
Exhibit 17: DEBs products in EMEA
Exhibit 18: DEBs market in EMEA 2016-2021 ($ millions)
Exhibit 19: DEBs market in Americas 2016-2021 ($ millions)
Exhibit 20: DEBs market in APAC 2016-2021 ($ millions)
Exhibit 21: Clinical trials for DEBs
Exhibit 22: Market share of vendors in global DEBs market 2016
Exhibit 23: B. Braun Melsungen: Key highlights
Exhibit 24: B. Braun Melsungen: Strength assessment
Exhibit 25: B. Braun Melsungen: Strategy assessment
Exhibit 26: B. Braun Melsungen: Opportunity assessment
Exhibit 27: Cook Medical: Strength assessment
Exhibit 28: Cook Medical: Strategy assessment
Exhibit 29: Cook Medical: Opportunity assessment
Exhibit 30: C.R. Bard: Key highlights
Exhibit 31: C.R Bard: Strength assessment
Exhibit 32: C.R Bard: Strategy assessment
Exhibit 33: C.R Bard: Opportunity assessment
Exhibit 34: Eurocor: Strength assessment
Exhibit 35: Eurocor: Strategy assessment
Exhibit 36: Eurocor: Opportunity assessment
Exhibit 37: Medtronic: Key highlights
Exhibit 38: Medtronic: Strength assessment
Exhibit 39: Medtronic: Strategy assessment
Exhibit 40: Medtronic: Opportunity assessment
